Primerica (PRI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
29 Jun, 2026Opening remarks and agenda
Meeting called to order by the Chairman, with introduction of the Inspector of Elections and recognition of directors and senior executives present, both in person and by phone.
Notice of meeting, agenda, and rules were distributed to all stockholders of record, with confirmation of a quorum representing at least 90% of outstanding shares.
Three matters were scheduled for consideration: election of directors, advisory vote on executive compensation, and ratification of the independent auditor.
Board and executive committee updates
Two directors, Gary Crittenden and Beatriz Perez, are stepping down, with the Corporate Governance Committee initiating a search for replacements.
No nominees are being presented for these vacancies at this meeting, resulting in two open board seats post-meeting.
Shareholder proposals
No additional nominations or proposals were received beyond those in the proxy statement; only the scheduled matters were considered.
Latest events from Primerica
- Q3 2024 net income from continuing operations rose 24% on 11% revenue growth.PRI
Q3 20249 Jul 2026 - All proposals passed with overwhelming support and no questions were raised by stockholders.PRI
AGM 202527 Jun 2026 - Record ISP sales drove 9% revenue growth and 19% higher EPS, with strong capital returns.PRI
Q1 20268 May 2026 - Record ISP sales and asset growth fueled double-digit earnings and capital returns.PRI
Q4 202513 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 annual meeting.PRI
Proxy filing2 Apr 2026 - Solid 2025 results, strong governance, and enhanced ESG drive board and pay proposals.PRI
Proxy filing2 Apr 2026 - Record 2025 financials and robust capital returns highlight scalable growth and strong risk management.PRI
Investor presentation25 Mar 2026 - Record ISP sales and 8% revenue growth drove higher earnings and capital returns.PRI
Q3 20253 Feb 2026 - Adjusted EPS up 18% and record sales force, despite Senior Health exit and impairment.PRI
Q2 20242 Feb 2026